During a Case-Based Roundtable® event, Natalie Galanina, MD, discussed data from the ZUMA-7 and TRANSFORM trials in the first ...

Dr Annalisa Morgan previews discussions on disease-modifying therapies, emerging treatments such as CAR T-cell therapy, and ...

In the wake of novel bispecific and chimeric antigen receptor T-cell therapies for various cancers, geography still plays a big role in patients' abilities to receive such treatments.

Steve Pruisner walked 110 miles, step by step during his on the adult stem cell transplant unit at University of Iowa Health ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Interviews revealed what patients and their caregivers focus on and needed support throughout the CAR-T therapy trajectory.

Chimeric antigen receptor T-cell therapy has been really instrumental in how we treat patients with myeloma. It has really changed the face of how we treat this disease, so since 2021, we've had two ...

T-cell therapy for eligible myeloma patients. The immunotherapy, which harnesses the body’s own immune system to fight blood cancer, will initially be available at HCA at University College Hospital ...

Research analysts at StockNews.com started coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a report released on Wednesday. The brokerage set a “hold” rating on the ...

Poor physical performance in patients with non-Hodgkin lymphoma receiving CAR T-cell therapy was linked to worse survival and ...